Physician profile
Jon L Schram
NPI 1053335018
$260,523.09
in general payments reported to CMS, 2019-2025
20 companies · $97K in 2025
The $97K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $513 · 2021: $16K · 2022: $13K · 2023: $65K · 2024: $55K · 2025: $97K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $151K · Travel and Lodging: $37K · Consulting Fee: $23K · Food and Beverage: $3,349 · Acquisitions: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $151,262.50 |
| Travel and Lodging | $37,198.16 |
| Consulting Fee | $23,100.00 |
| Food and Beverage | $3,348.67 |
| Acquisitions | $1,665.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $213,986.96 | 2023-2025 | Titan Sgs Bailout Chuck, Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Standard Bariatrics, INC. | $29,638.20 | 2019-2023 | Titan Sgs Standard Gastric Stapler |
| Ethicon INC. | $6,978.73 | 2019 | |
| Baxter Healthcare | $2,479.80 | 2019 | |
| Heron Therapeutics, INC. | $2,457.60 | 2022-2023 | Aponvie |
| Medical Device Business Services, INC. | $1,890.00 | 2019-2023 | |
| Novo Nordisk INC | $869.78 | 2019-2025 | Wegovy, Saxenda |
| Ethicon US, LLC | $688.18 | 2019-2024 | Surgicel Nu-Knit, Ethicon, Linx Reflux Management System |
| Intuitive Surgical, INC. | $674.98 | 2019-2025 | |
| Medtronic, INC. | $289.95 | 2022-2024 | Ligasure |
| W. L. Gore & Associates, INC. | $228.49 | 2019-2022 | |
| Teleflex Medical Incorporated | $140.82 | 2023 | Titan Sgs Standard Gastric Stapler |
| Lilly USA, LLC | $55.68 | 2024-2025 | Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $33.85 | 2024 | Gattex |
| Olympus America INC. | $29.95 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $26.27 | 2023 | Integra, Surgimend, Omnigraft |
| Acacia Pharma INC | $20.72 | 2022 | |
| Reshape Lifesciences INC. | $17.24 | 2022 | |
| Abbvie INC. | $15.89 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,068.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Schram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.